BMI was significantly higher in our cohort of patients with COVID‐19 compared with those with non‐COVID‐19 respiratory illness but nonetheless there was no relationship between PAI‐1 and BMI or with leptin, a biomarker of metabolic syndrome.45 This evidence concerns the gene SERPINE1 and metabolic syndrome.